News Sanofi boosts ‘connected insulin’ push with Glooko deal The alliance will pair Glooko's digital health platform with Sanofi's SoloSmart insulin device.
News Novo Nordisk sheds billions in value on obesity data Novo Nordisk data on obesity candidate CagriSema falls short of expectations, wiping around $94 billion off its market valuation.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
